About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
Optimising kangaroo care to reduce neonatal severe infection/sepsis and resistant bacterial colonisation among high-risk infants in neonatal intensive care: a pragmatic, multicentre, parallel cluster randomised hybrid implementation–effectiveness trial (NeoDeco)
Effect of dolutegravir on folate, vitamin B12 and mean corpuscular volume levels among children and adolescents with HIV: a sub-study of the ODYSSEY randomized controlled trial
Relative bioavailability of dolutegravir (DTG) and emtricitabine/tenofovir alafenamide fumarate (F/TAF) administered as paediatric tablet formulations in healthy volunteers
D3 trial completes recruitment ahead of schedule!
Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19
COVID-19 and MIS-C treatment in children—results from an international survey
Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV
PediCAP trial completes recruitment, investigating more child-friendly treatment options for severe community-acquired pneumonia